Karine Bouhier Leporrier
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Pancreatic and Hepatic Oncology Research, Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study)(2025)19 cited
- → Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX)(2020)17 cited
- → Prevention of 5-FU-induced health-threatening toxicity by pretherapeutic DPD deficiency screening: Medical and economic assessment of a multiparametric approach.(2013)8 cited
- → Prevention of 5-FU-induced toxicities using pretherapeutic DPD deficiency screening: Medical and economic assessment of a multiparametric approach.(2013)4 cited
- → Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: a multicentric retrospective study(2023)3 cited
- → 449TiP Evaluation of regorafenib treatment PERSOnalization based on therapeutic drug monitoring in patients with metastatic colorectal cancer (mCRC): RePERSO study(2022)1 cited
- → REMINET: A European, multicentre, PHASE II/III randomized double-blind, placebo-controlled study evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours.(2016)1 cited
- → Everolimus after transarterial liver therapy of metastases from gastrointestinal neuroendocrine tumors: The FFCD 1104-EVACEL-GTE phase II study(2018)
- → Everolimus after Hepatic Arterial Embolisation Therapy of Metastases from Gastrointestinal Neuroendocrine Tumours: The FFCD 1104-EVACEL-GTE Phase II Study(2018)
- → FOLFIRI followed by radiochemotherapy and surgery in locally advanced gastric cancer: FFCD 0308 phase II trial.(2011)